Refer a friend
Refer a friend or family member to join research study today and you will receive a $55 Visa gift card when they enroll.
Pick a friend or a family member who is new to Charter Research.
Fill out the form below.
Fill Out The Form
Study
Alzheimer’s Neurotransmitter Study
A new oral medication
For those with mild-to-moderate Alhzeimer's disease
Patients with mild to moderate Alzheimer’s disease often have negative changes in how efficiently their bodies process dopamine, a neurotransmitter that helps nerve cells send messages to each other. This can lead to adverse changes in personality, mood, and behavior.
This investigational drug enhances the body’s ability to utilize dopamine. In theory, this may boost dopamine’s effectiveness in someone with Alzheimer’s. The study will look at whether the drug is a safe and effective treatment to improve thinking (cognition), memory, and executive function in patients with mild-to-moderate Alzheimer’s disease.
READ MORE ABOUT THIS STUDY |
Who is eligible?
You may qualify for this study if:
- You are 50-80 years old
- You have gradual & progressive decline in memory function for more than 6 months.
- You have historical evidence of Alzheimer's disease
Sign Up
Schedule Your Assessment
Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.
Get More Information
Locations supporting this study
-
Orlando
1724 N. Mills Avenue, Suite 200Orlando, FL 32803Hours of Operation
Monday thru Friday
8am to 5pm -
The Villages
1025 Lake Sumter LandingThe Villages, FL 32162Hours of Operation
Monday thru Friday
8am to 5pmContact